RIDDHI SIDDHI GLUCO BIOLS LTD.-$

Riddhi Siddhi Gluco Biols Ltd has announced a Board of Directors meeting scheduled for August 13, 2026. The primary agenda is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, on both standalone and consolidated bases. The meeting will also adopt the limited review reports from the statutory auditors for these results. Concurrently, the company has confirmed that the trading window for designated persons and their relatives, which closed on July 1, 2026, will remain shut until 48 hours after the financial results are declared.

Riddhi Siddhi Gluco Biols Limited has completed the acquisition of a 26% partnership interest in Clean Max Pluto Solar Power LLP from Cargill India Private Limited. This acquisition, part of a larger Asset Purchase Agreement for a manufacturing facility in Davangere, Karnataka, allows the company to qualify as a captive user. It will enable Riddhi Siddhi Gluco Biols to secure long-term, cost-competitive solar/wind power for its proposed manufacturing facility.

Riddhi Siddhi Gluco Biols Ltd has announced the closure of its trading window for dealing in securities. This closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The window will be shut for all designated persons and their immediate relatives starting from July 1, 2026. It will remain closed until 48 hours after the public announcement of the company's unaudited financial results for the quarter ended June 30, 2026. Designated individuals and their relatives are advised against trading in the company's securities during this period.

Vital Connections LLP has disclosed a significant sale of its shareholding in Riddhi Siddhi Gluco Biols Limited. The transaction involved the sale of 8,23,422 equity shares, representing 11.55% of the total share capital. Prior to this sale, Vital Connections LLP held 8,56,009 shares, constituting 12.01% of the company's voting rights. Following the sale, their holding has reduced to 32,587 shares, or 0.46%. The sale was conducted through the stock exchange mechanism as an Offer for Sale. The transaction occurred on June 22-23, 2026.

Riddhi Siddhi Gluco Biols Limited announced the successful completion of an Offer for Sale (OFS) by Vital Connections LLP, a promoter group shareholder. The OFS involved the sale of 8,23,422 equity shares, representing 11.55% of the company's total equity. This transaction, conducted on June 22-23, 2026, was aimed at achieving the Minimum Public Shareholding (MPS) requirements mandated by SEBI regulations. Following the OFS, the promoter and promoter group's aggregate shareholding has reduced from 86.55% to 75%, bringing the public shareholding to 25% and fulfilling the 25% MPS requirement.

Mr. Pratik Mahendra Shah, Non-Executive Independent Director of Riddhi Siddhi Gluco Biols Ltd, has tendered his resignation from the board. The resignation is effective from June 22, 2026. The reason cited for his departure is increased commitment due to the growth of his personal business, requiring greater time and focus. Mr. Shah has confirmed that there are no other material reasons for his resignation. The company has enclosed his resignation letter and relevant disclosures as per SEBI regulations.

Vital Connections LLP, a promoter group shareholder of Riddhi Siddhi Gluco Biols Ltd, proposes to sell up to 8,23,422 equity shares, representing 11.55% of the total paid-up capital. The Offer for Sale (OFS) will be conducted on June 22, 2026, for non-retail investors and June 23, 2026, for retail investors, through the stock exchange mechanism. This sale is primarily aimed at achieving the company's Minimum Public Shareholding (MPS) requirements, following a SEBI order and subsequent modifications by the Securities Appellate Tribunal (SAT). Kotak Securities Limited is appointed as the Seller's Broker for this transaction.

Riddhi Siddhi Gluco Biols Ltd has issued a corrigendum to its consolidated financial results for the quarter and financial year ended March 31, 2026. The revision addresses an error on page 2 of the Consolidated Audited Balance Sheet, where Current Tax Assets (Net) amounting to ₹39.94 Lakhs were missing. The company has rectified the error and submitted revised consolidated financial results.

Riddhi Siddhi Gluco Biols Ltd's Board of Directors recommended a final dividend of ₹3 per share (30% of face value) at its meeting on May 25, 2026. The board also approved audited financial results for the year ended March 31, 2026, and amendments to the Memorandum of Association, including a change to the Main Object Clause and shifting the registered office from Gujarat to Haryana, subject to shareholder approval. Additionally, M/s. J S Varma & Co was appointed as Internal Auditor for FY 2026-27.

Riddhi Siddhi Gluco Biols Ltd's board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board recommended a dividend of ₹3 per share (30%) and approved amendments to the Memorandum of Association, including changes to the Main Object Clause and shifting the registered office from Gujarat to Haryana, subject to shareholder and regulatory approvals. They also approved the appointment of M/s. J S Varma & Co as Internal Auditor for FY 2026-27.